CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,676,804
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-28 | Turtle Cameron See Remarks | Sale | −8,563 | $69.94 | $599K | 12,568 |
| 2020-12-28 | Turtle Cameron See Remarks | Option exercise · Stock Option (Right to Buy) | −7,500 | 255,500 | ||
| 2020-12-28 | Turtle Cameron See Remarks | Option exercise · Stock Option (Right to Buy) | −6,000 | 31,766 | ||
| 2020-12-28 | Turtle Cameron See Remarks | Option exercise · Stock Option (Right to Buy) | −6,000 | 56,042 | ||
| 2020-12-21 | SCHELLER RICHARD H See Remarks | Sale | −14,928 | $64.81 | $967K | 91,333 |
| 2020-12-21 | SCHELLER RICHARD H See Remarks | Sale | −45,473 | $65.48 | $3.0M | 45,860 |
| 2020-12-18 | SCHELLER RICHARD H See Remarks | Sale | −27,105 | $64.99 | $1.8M | 109,156 |
| 2020-12-18 | SCHELLER RICHARD H See Remarks | Sale | −2,895 | $65.78 | $190K | 106,261 |
| 2020-12-15 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +8,912 | 8,912 | ||
| 2020-12-15 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +10,832 | 10,832 | ||
| 2020-12-15 | Sinha Uma Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +5,717 | 5,717 | ||
| 2020-12-15 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +4,456 | 4,456 | ||
| 2020-12-15 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +3,137 | 3,137 | ||
| 2020-12-15 | HENDERSON MICHAEL THOMAS Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +2,199 | 2,199 | ||
| 2020-12-15 | SCHELLER RICHARD H See Remarks | Option exercise | +29,277 | $17.00 | $498K | 167,704 |
| 2020-12-15 | SCHELLER RICHARD H See Remarks | Sale | −12,091 | $59.81 | $723K | 155,613 |
| 2020-12-15 | SCHELLER RICHARD H See Remarks | Sale | −19,352 | $60.73 | $1.2M | 136,261 |
| 2020-12-15 | SCHELLER RICHARD H See Remarks | Option exercise · Stock Option (Right to Buy) | −29,277 | 53,388 | ||
| 2020-12-01 | HENDERSON MICHAEL THOMAS Chief Business Officer | Option exercise | +10,000 | $1.05 | $11K | 284,211 |
| 2020-12-01 | HENDERSON MICHAEL THOMAS Chief Business Officer | Sale | −3,028 | $51.12 | $155K | 281,183 |
Page 41 of 44 · 868 trades